The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus.
about
The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.Effect of pioglitazone on excitotoxic neuronal damage in the mouse hippocampusPPAR agonists as therapeutics for CNS trauma and neurological diseasesPPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.Concordance of Several Subcellular Interactions Initiates Alzheimer's Dementia: Their Reversal Requires Combination Treatment.Increased calcineurin expression after pilocarpine-induced status epilepticus is associated with brain focal edema and astrogliosis.Isoflurane exposure regulates the cell viability and BDNF expression of astrocytes via upregulation of TREK‑1.The Calcineurin Inhibitor FK506 Prevents Cognitive Impairment by Inhibiting Reactive Astrogliosis in Pilocarpine-Induced Status Epilepticus Rats.Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.Within the Brain: The Renin Angiotensin System.Effects of dexamethasone on the Li-pilocarpine model of epilepsy: protection against hippocampal inflammation and astrogliosis.
P2860
Q30576758-F91A1848-C7D8-44DE-A5F1-0F2465DFC315Q33921641-09008872-D138-46DC-8448-A660818D0ACEQ35597512-31A9AFEF-DBF3-4898-ABC2-5579D41F50EFQ37400355-B2969044-F371-4B85-9073-7115B00179D7Q38776236-0AA8EA2A-48B8-4CDD-BF54-1A2D43426077Q38777732-F779843B-300A-4ED0-A8B1-BE779B69D793Q38829895-3FB44099-E034-40C8-B61F-34C9C9131917Q40911563-796BAE2D-F1EA-4261-B5BF-704C90844CC1Q47248747-F15808B9-AC24-48CA-8B3F-84EED431FA70Q47698987-6B1F3DDF-6AEE-449A-B478-0BC50459EF8DQ48569089-8BCADA94-3B63-43DD-AA4A-F265EC4EC487Q51762826-96AD2FD8-89B7-45DC-BE26-1FCF8B77423AQ55426524-A9FF39BE-1577-4A49-9311-3A1FF212C0F3
P2860
The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The PPARγ agonist rosiglitazon ...... ne-induced status epilepticus.
@en
The PPARγ agonist rosiglitazon ...... ne-induced status epilepticus.
@nl
type
label
The PPARγ agonist rosiglitazon ...... ne-induced status epilepticus.
@en
The PPARγ agonist rosiglitazon ...... ne-induced status epilepticus.
@nl
prefLabel
The PPARγ agonist rosiglitazon ...... ne-induced status epilepticus.
@en
The PPARγ agonist rosiglitazon ...... ne-induced status epilepticus.
@nl
P2093
P2860
P1476
The PPARγ agonist rosiglitazon ...... ne-induced status epilepticus.
@en
P2093
Wang HuQing
Zhan ShuQin
Zhang GuiLian
P2860
P2888
P304
P356
10.1007/S10072-011-0774-2
P577
2011-09-14T00:00:00Z